Westlake Chemical Partners LP — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Westlake Chemical Partners LP filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.17B | Mar 4, 2026 |
| FY2025 | Dec 31, 2024 | $1.14B | Mar 4, 2026 |
| FY2025 | Dec 31, 2023 | $1.19B | Mar 4, 2026 |
| FY2024 | Dec 31, 2022 | $1.59B | Mar 5, 2025 |
| FY2023 | Dec 31, 2021 | $1.21B | Feb 28, 2024 |
| FY2020 | Dec 31, 2020 | $245.65M | Mar 2, 2021 |
| FY2020 | Sep 30, 2020 | $231.97M | Mar 2, 2021 |
| FY2020 | Jun 30, 2020 | $238.50M | Mar 2, 2021 |
| FY2020 | Mar 31, 2020 | $250.55M | Mar 2, 2021 |
| FY2020 | Dec 31, 2019 | $272.80M | Mar 2, 2021 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | $250.24M | Mar 1, 2023 |
| FY2022 | Dec 31, 2021 | $188.27M | Mar 1, 2023 |
| FY2022 | Dec 31, 2020 | $78.43M | Mar 1, 2023 |
| FY2021 | Dec 31, 2019 | $154.25M | Mar 2, 2022 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $308.65M | Mar 1, 2018 |
| FY2017 | Sep 30, 2017 | $296.78M | Mar 1, 2018 |
| FY2017 | Jun 30, 2017 | $290.11M | Mar 1, 2018 |
| FY2017 | Mar 31, 2017 | $277.45M | Mar 1, 2018 |
| FY2017 | Dec 31, 2016 | $293.94M | Mar 1, 2018 |
| FY2017 | Sep 30, 2016 | $229.35M | Mar 1, 2018 |
| FY2017 | Jun 30, 2016 | $210.84M | Mar 1, 2018 |
| FY2017 | Mar 31, 2016 | $252.60M | Mar 1, 2018 |
| FY2016 | Dec 31, 2015 | $248.51M | Mar 7, 2017 |
| FY2016 | Sep 30, 2015 | $248.62M | Mar 7, 2017 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $347.85M | Mar 4, 2026 |
| FY2025 | Dec 31, 2024 | $418.94M | Mar 4, 2026 |
| FY2025 | Dec 31, 2023 | $387.46M | Mar 4, 2026 |
| FY2024 | Dec 31, 2022 | $377.37M | Mar 5, 2025 |
| FY2023 | Dec 31, 2021 | $441.71M | Feb 28, 2024 |
| FY2020 | Dec 31, 2020 | $84.91M | Mar 2, 2021 |
| FY2020 | Sep 30, 2020 | $100.39M | Mar 2, 2021 |
| FY2020 | Jun 30, 2020 | $90.03M | Mar 2, 2021 |
| FY2020 | Mar 31, 2020 | $103.55M | Mar 2, 2021 |
| FY2020 | Dec 31, 2019 | $103.60M | Mar 2, 2021 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $48.70M | Mar 4, 2026 |
| FY2025 | Dec 31, 2024 | $62.39M | Mar 4, 2026 |
| FY2025 | Dec 31, 2023 | $54.28M | Mar 4, 2026 |
| FY2024 | Dec 31, 2022 | $64.17M | Mar 5, 2025 |
| FY2023 | Dec 31, 2021 | $82.55M | Feb 28, 2024 |
| FY2020 | Dec 31, 2020 | $15.03M | Mar 2, 2021 |
| FY2020 | Sep 30, 2020 | $18.54M | Mar 2, 2021 |
| FY2020 | Jun 30, 2020 | $14.86M | Mar 2, 2021 |
| FY2020 | Mar 31, 2020 | $17.75M | Mar 2, 2021 |
| FY2020 | Dec 31, 2019 | $17.37M | Mar 2, 2021 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $319.58M | Mar 4, 2026 |
| FY2025 | Dec 31, 2024 | $390.44M | Mar 4, 2026 |
| FY2025 | Dec 31, 2023 | $357.71M | Mar 4, 2026 |
| FY2024 | Dec 31, 2022 | $347.69M | Mar 5, 2025 |
| FY2023 | Dec 31, 2021 | $410.69M | Feb 28, 2024 |
| FY2020 | Dec 31, 2020 | $77.61M | Mar 2, 2021 |
| FY2020 | Sep 30, 2020 | $94.14M | Mar 2, 2021 |
| FY2020 | Jun 30, 2020 | $83.89M | Mar 2, 2021 |
| FY2020 | Mar 31, 2020 | $97.35M | Mar 2, 2021 |
| FY2020 | Dec 31, 2019 | $95.75M | Mar 2, 2021 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $28.27M | Mar 4, 2026 |
| FY2025 | Dec 31, 2024 | $28.50M | Mar 4, 2026 |
| FY2025 | Dec 31, 2023 | $29.75M | Mar 4, 2026 |
| FY2024 | Dec 31, 2022 | $29.68M | Mar 5, 2025 |
| FY2023 | Dec 31, 2021 | $31.02M | Feb 28, 2024 |
| FY2022 | Dec 31, 2020 | $25.90M | Mar 1, 2023 |
| FY2021 | Dec 31, 2019 | $29.28M | Mar 2, 2022 |
| FY2020 | Dec 31, 2018 | $27.59M | Mar 2, 2021 |
| FY2019 | Dec 31, 2017 | $29.26M | Feb 28, 2020 |
| FY2018 | Dec 31, 2016 | $24.89M | Mar 1, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $280.47M | Mar 4, 2026 |
| FY2025 | Dec 31, 2024 | $485.00M | Mar 4, 2026 |
| FY2025 | Dec 31, 2023 | $452.00M | Mar 4, 2026 |
| FY2024 | Dec 31, 2022 | $463.74M | Mar 5, 2025 |
| FY2023 | Dec 31, 2021 | $408.44M | Feb 28, 2024 |
| FY2022 | Dec 31, 2020 | $373.40M | Mar 1, 2023 |
| FY2021 | Dec 31, 2019 | $450.81M | Mar 2, 2022 |
| FY2020 | Dec 31, 2018 | $436.15M | Mar 2, 2021 |
| FY2019 | Dec 31, 2017 | $537.36M | Feb 28, 2020 |
| FY2018 | Dec 31, 2016 | $287.73M | Mar 1, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $78.82M | Mar 4, 2026 |
| FY2025 | Dec 31, 2024 | $48.97M | Mar 4, 2026 |
| FY2025 | Dec 31, 2023 | $46.82M | Mar 4, 2026 |
| FY2024 | Dec 31, 2022 | $54.12M | Mar 5, 2025 |
| FY2023 | Dec 31, 2021 | $81.17M | Feb 28, 2024 |
| FY2022 | Dec 31, 2020 | $36.97M | Mar 1, 2023 |
| FY2021 | Dec 31, 2019 | $43.71M | Mar 2, 2022 |
| FY2020 | Dec 31, 2018 | $39.86M | Mar 2, 2021 |
| FY2019 | Dec 31, 2017 | $68.86M | Feb 28, 2020 |
| FY2018 | Dec 31, 2016 | $299.64M | Mar 1, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.26B | Mar 4, 2026 |
| FY2025 | Dec 31, 2024 | $1.29B | Mar 4, 2026 |
| FY2024 | Dec 31, 2023 | $1.32B | Mar 5, 2025 |
| FY2023 | Dec 31, 2022 | $1.37B | Feb 28, 2024 |
| FY2022 | Dec 31, 2021 | $1.48B | Mar 1, 2023 |
| FY2021 | Dec 31, 2020 | $1.36B | Mar 2, 2022 |
| FY2020 | Dec 31, 2019 | $1.39B | Mar 2, 2021 |
| FY2019 | Dec 31, 2018 | $1.46B | Feb 28, 2020 |
| FY2018 | Dec 31, 2017 | $1.52B | Mar 1, 2019 |
| FY2017 | Dec 31, 2016 | $1.56B | Mar 1, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $454.18M | Mar 4, 2026 |
| FY2025 | Dec 31, 2024 | $458.64M | Mar 4, 2026 |
| FY2024 | Dec 31, 2023 | $460.59M | Mar 5, 2025 |
| FY2023 | Dec 31, 2022 | $468.27M | Feb 28, 2024 |
| FY2022 | Dec 31, 2021 | $508.00M | Mar 1, 2023 |
| FY2021 | Dec 31, 2020 | $441.35M | Mar 2, 2022 |
| FY2020 | Dec 31, 2019 | $441.32M | Mar 2, 2021 |
| FY2019 | Dec 31, 2018 | $528.04M | Feb 28, 2020 |
| FY2018 | Dec 31, 2017 | $516.53M | Mar 1, 2019 |
| FY2017 | Dec 31, 2016 | $634.27M | Mar 1, 2018 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.81M | Mar 4, 2026 |
| FY2025 | Dec 31, 2024 | $5.81M | Mar 4, 2026 |
| FY2024 | Dec 31, 2023 | $5.81M | Mar 5, 2025 |
| FY2023 | Dec 31, 2022 | $5.81M | Feb 28, 2024 |
| FY2022 | Dec 31, 2021 | $5.81M | Mar 1, 2023 |
| FY2021 | Dec 31, 2020 | $5.81M | Mar 2, 2022 |
| FY2020 | Dec 31, 2019 | $5.81M | Mar 2, 2021 |
| FY2019 | Dec 31, 2018 | $5.81M | Feb 28, 2020 |
| FY2018 | Dec 31, 2017 | $5.81M | Mar 1, 2019 |
| FY2017 | Dec 31, 2016 | $5.81M | Mar 1, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $44.27M | Mar 4, 2026 |
| FY2025 | Dec 31, 2024 | $58.32M | Mar 4, 2026 |
| FY2024 | Dec 31, 2023 | $58.62M | Mar 5, 2025 |
| FY2023 | Dec 31, 2022 | $64.78M | Feb 28, 2024 |
| FY2022 | Dec 31, 2021 | $17.06M | Mar 1, 2023 |
| FY2021 | Dec 31, 2020 | $17.15M | Mar 2, 2022 |
| FY2020 | Dec 31, 2019 | $19.92M | Mar 2, 2021 |
| FY2019 | Dec 31, 2018 | $19.74M | Feb 28, 2020 |
| FY2018 | Dec 31, 2017 | $27.01M | Mar 1, 2019 |
| FY2018 | Dec 31, 2016 | $88.90M | Mar 1, 2019 |